RC
MXCT icon

RBF Capital’s MaxCyte MXCT Stock Holding History

RBF Capital’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Buy
+1,322,443
New +$1.32M 0.07% 235

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

RBF Capital's MXCT Position: Q2 2026 in Review

RBF Capital opened a new position in MaxCyte (MXCT) in Q2 2026: 1,322,443 shares worth $1.63M. The stake represents 0.07% of the portfolio and ranks #235 among its holdings.

123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • RBF Capital held 1,322,443 shares of MaxCyte worth $1.63M as of Q2 2026.
  • MaxCyte was a new RBF Capital position in Q2 2026.
  • MaxCyte made up 0.07% of RBF Capital's portfolio in Q2 2026, its #235 holding.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on RBF Capital's 13F filing for Q2 2026, filed 14 Aug 2026.